Temesta and abnormal behaviour Patient Reports February 12, 2012

Temesta Side Effects Report #4588334-1
Temesta side effect was reported by a Consumer or non-health professional from on Jan 28, 2005. Male patient, 85 years of age, was treated with Temesta. After drug was administered, patient experienced the following side effects: abnormal behaviour, confusional state, disorientation, electroencephalogram abnormal, encephalopathy, hallucination, visual, hyperreflexia, myoclonus. Temesta dosage: 1 MG Q DAY PO. During the same period patient was treated with ALLOPURINOL, PLAVIX, ZYPREXA, IMOVANE, ZOCOR. Patient was hospitalized. Patient recovered.

Temesta Side Effects Report #4677256-3
Temesta side effect was reported by a Health Professional from on May 12, 2005. Male patient, 85 years of age, was treated with Temesta. After drug was administered, patient experienced the following side effects: abnormal behaviour, confusional state, disorientation, encephalopathy, hyperreflexia. Temesta dosage: 1 MG Q DAY PO. During the same period patient was treated with ALLOPURINOL, PLAVIX, ZYPREXA, IMOVANE, ZOCOR. Patient was hospitalized. Patient recovered.

Temesta Side Effects Report #5291391-0
Temesta side effect was reported by a Health Professional from SWITZERLAND on Mar 16, 2007. Female patient, 81 years of age, weighting 101.6 lb, was treated with Temesta. After drug was administered, patient experienced the following side effects: abnormal behaviour, agitation, dehydration, delirium, depressed level of consciousness, fluid intake reduced, hallucination, visual, renal failure, restlessness. Temesta dosage: 2.5 MG Q DAY PO. During the same period patient was treated with ZYPREXA, ASPIRIN. Patient was hospitalized. Patient recovered.

Temesta Side Effects Report #5361140-6
Temesta side effect was reported by a Consumer or non-health professional from SWITZERLAND on May 29, 2007. Female patient, weighting 101.6 lb, was treated with Temesta. After drug was administered, patient experienced the following side effects: abnormal behaviour, agitation, altered state of consciousness, blood glucose decreased, dehydration, delirium, fluid intake reduced, hallucination, visual, renal failure. Temesta dosage: 2.5 MG QD ORAL. During the same period patient was treated with ZYPREXA, ASPIRIN. Patient was hospitalized. Patient recovered.